Get the Stockscreener App
1.66
0.60%
-0.01
Cytomed Therapeutics Ltd stock is traded at $1.66, with a volume of 10,771.
It is down -0.60% in the last 24 hours and down -13.99% over the past month.
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.
See More
Previous Close:
$1.67
Open:
$1.655
24h Volume:
10,771
Relative Volume:
0.09
Market Cap:
$19.48M
Revenue:
-
Net Income/Loss:
$-3.15M
P/E Ratio:
-5.4391
EPS:
-0.3052
Net Cash Flow:
$-2.23M
1W Performance:
-6.21%
1M Performance:
-13.99%
6M Performance:
-22.25%
1Y Performance:
-38.75%
1-Day Range:
$1.63
$1.68
1-Week Range:
$1.50
$2.12
52-Week Range:
$1.50
$4.0499
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
Name
Cytomed Therapeutics Ltd
Sector
Industry
Phone
-
Address
-
Compare GDTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
1.66 | 19.60M | 0 | -3.15M | -2.23M | -0.3052 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cytomed Therapeutics Ltd Stock (GDTC) Latest News
CytoMed stock jumps after announcing clinical trial partnership in Malaysia By Investing.com - Investing.com South Africa
CytoMed stock jumps after announcing clinical trial partnership in Malaysia - Investing.com India
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital - Investing.com
CytoMed Therapeutics enters clinical trial agreement with Malaysian hospital By Investing.com - Investing.com South Africa
CytoMed Therapeutics (NASDAQ: GDTC) plans first-in-human gamma delta T cell trial in Malaysia - Stock Titan
CytoMed Therapeutics (NASDAQ: GDTC) to run first-in-human Malaysia trial of donor-derived γδ T cells - Stock Titan
CytoMed Therapeutics (GDTC) Stock Analysis Report | Financials & Insights - Benzinga
Why CytoMed Therapeutics Limited (F98) stock appears on watchlists2025 Price Momentum & Reliable Trade Execution Plans - Newser
Will CytoMed Therapeutics Limited (F98) stock benefit from Fed rate cuts2025 Short Interest & Intraday High Probability Setup Alerts - Newser
CytoMed acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
CytoMed Therapeutics acquires T Cell technology from UK to treat cancers in China and India - BioSpectrum Asia
Applying Wyckoff theory to CytoMed Therapeutics Limited stock2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
What earnings margins imply for CytoMed Therapeutics Limited (F98) stockQuarterly Trade Review & AI Driven Stock Movement Reports - newser.com
How CytoMed Therapeutics Limited stock reacts to job market dataPortfolio Update Summary & Daily Technical Stock Forecast Reports - newser.com
Can you recover from losses in CytoMed Therapeutics LimitedTrade Risk Report & AI Driven Stock Reports - newser.com
CytoMed Therapeutics Ltd (GDTC) can make a big difference with a little luck - Setenews
Will CytoMed Therapeutics Limited stock outperform Dow Jones indexJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Why CytoMed Therapeutics Limited stock remains a top recommendationWatch List & Safe Entry Point Identification - newser.com
CytoMed acquires TC BioPharm’s gamma delta T cell technology By Investing.com - Investing.com Canada
How dovish Fed policy supports CytoMed Therapeutics Limited (F98) stock - newser.com
Can CytoMed Therapeutics Limited (F98) stock resist broad market declinesMarket Risk Summary & Daily Profit Focused Stock Screening - newser.com
What insider trading reveals about CytoMed Therapeutics Limited stockQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Will CytoMed Therapeutics Limited (F98) stock maintain strong growthProduct Launch & Stepwise Trade Signal Implementation - newser.com
CytoMed acquires TC BioPharm's gamma delta T cell technology By Investing.com - Investing.com Nigeria
[6-K] CytoMed Therapeutics Ltd Current Report (Foreign Issuer) | GDTC SEC FilingForm 6-K - Stock Titan
Royal Caribbean (NYSE: RCL) launches unsecured notes sale to finance Celebrity Xcel - Stock Titan
Is CytoMed Therapeutics Limited (F98) stock a fit for income portfoliosMarket Risk Summary & Free Low Drawdown Momentum Trade Ideas - newser.com
Will CytoMed Therapeutics Limited (F98) stock keep high P E multiples2025 Key Lessons & Weekly Top Stock Performers List - newser.com
Is a relief rally coming for CytoMed Therapeutics Limited holdersMarket Activity Summary & Fast Gain Swing Alerts - newser.com
CytoMed Therapeutics Limited recovery potential after sell offJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - newser.com
Is CytoMed Therapeutics Limited (F98) stock undervalued historically2025 Market Outlook & Risk Managed Investment Signals - newser.com
How to monitor CytoMed Therapeutics Limited with trend dashboardsJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
Is CytoMed Therapeutics Limited stock attractive for income investorsMarket Risk Summary & Community Consensus Picks - newser.com
Is CytoMed Therapeutics Limited stock vulnerable to regulatory risksJuly 2025 Momentum & Technical Pattern Based Signals - newser.com
GDTC Stock Institutional Owners - Quiver Quantitative
CytoMed Therapeutics Limited (GDTC) Stock Price, News, Quote & History - Yahoo! Finance Canada
There is no way CytoMed Therapeutics Ltd (GDTC) can keep these numbers up - setenews.com
CytoMed Therapeutics secures $500,000 investment for subsidiary By Investing.com - Investing.com Nigeria
CytoMed Therapeutics Secures Non-Dilutive Investment for Subsidiary LongevityBank from ICH Capital and Updates on New China Strategy - The Manila Times
CytoMed Therapeutics Secures Non-Dilutive Investment for - GlobeNewswire
Cytomed Therapeutics Ltd Stock (GDTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):